Enterprise Value
74.25M
Cash
23.8M
Avg Qtr Burn
-1.633M
Short % of Float
1.90%
Insider Ownership
4.90%
Institutional Own.
13.90%
Qtr Updated
01/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CAR-T therapy (CER-T) Details Ovarian cancer, Cancer | Phase 1 Data readout | |
Breast Cancer Vaccine Details Breast cancer | Phase 1a Data readout |